Organigram Holdings Inc.

Five years into its legalization, the Canadian cannabis market reveals intriguing regional disparities and growth trends, as highlighted in the latest report from cannabis equity research firm Zuanic & Associates. Despite the usual market drivers like affordability, access, and variety, Canada...

Vape products in Canada's cannabis sector demonstrated significant year-over-year growth in Q3 2023, increasing by 21% and ranking third behind pre-rolls at (+25%) and concentrates at (+43%). In his latest report, Pablo Zuanic, a senior analyst at Zuanic & Associates delves into the...

OrganiGram Holdings Inc (NASDAQ:OGI), a Canadian cannabis operator producer, has increased its investment in Phylos Bioscience Inc., a U.S.-based cannabis genetics company. Following the achievement of a crucial milestone under their May 2023 loan agreement, Organigram has closed the second tranche...

Canada's cannabis industry is about to hit C$6 billion (nearly $4.4 billion) in retail sales. In its latest report, analysis firm Z&A looks into the thriving year-on-year surge in recreational sales and the worrisome downturn in the medical marijuana sector. The report...

US legal cannabis sales are predicted to exceed $28 billion in 2023, with promising regulatory developments such as the recommendation to "reschedule" cannabis by the HHS. Canada's cannabis exports have surged to C$160 million, a 50% increase year-on-year, and with new international...

The cannabis industry is witnessing an array of exciting new cannabis products, as leading players introduce groundbreaking developments that redefine the way we experience cannabis. From innovative pre-roll flavors and limited-time collections to refreshing CBD-infused beverages and unique strains...

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) has introduced its inaugural line of THCV products under the SHRED and Trailblazer brands. The company has invested strategically in Phylos Bioscience, a leading US-based cannabis genetics company to secure a competitive edge in the...

In an exclusive preview from Zuanic & Associates' recent cannabis equity research report, Benzinga reveals four key predictions for the next 18 months. The SAFE Banking bill is expected to pass in the fall of 2024. Key Senate players will aim for a "midpoint" compromise on add-...

Discover the latest cannabis products in this exclusive round-up from Benzinga. We've curated a diverse selection of new launches by cannabis operators, catering to both connoisseurs and casual enthusiasts. New Flowers' Strains By Canopy Growth Canopy Growth Corporation (TSX: WEED) (NASDAQ...

Organigram Holdings (NASDAQ: OGI), a major licensed producer of cannabis and cannabis-derived products in Canada, announced plans to consolidate its shares on a 4-to-1 basis. The move is aimed at maintaining the company's U.S. equity listing on the NASDAQ, which had warned Organigram...

In a challenge to Health Canada's recent decision to restrict the sale of cannabis extracts that go beyond the federal 10mg THC packaging limit, cannabis producer Organigram Holdings Inc. (NASDAQ: OGI) filed for a judicial review. Organigram is one of several companies that...

Greentank Technologies, a business-to-business technology company specializing in the design, development and manufacture of precision-made vaporization hardware and atomization technology, secured $16.5 million in Series B funding to accelerate growth in sustainable cannabis vaping tech...

On Thursday, Organigram Holdings Inc. (OGI.TO) (NASDAQ: OGI), a cannabis company focused on producing high-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, released its results for the third quarter ended May 31, 2022, revealing net revenue increased 88%...

Organigram Plans To Ramp Up Staff Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) posted financial results for the first quarter of fiscal 2021. The company reported a net loss of $34.4 million, or 17 cents per share on a diluted basis, which compares to a net loss of $900,000, or one...

iAnthus Touts 82% YoY Revenue Growth, Names Interim COO New York-based iAnthus Capital Holdings Inc. (CSE: IAN) (PINK: ITHUF) generated around $40.6 million in revenue during the third quarter of fiscal 2020. That's up by 17% sequentially and roughly 82% year-over-year. The...